Pravastatin for severe radiation breast scar tissue, with e-reports
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether pravastatin can improve severe radiation-related breast scarring and breast-related quality of life. It also studies whether using an electronic patient questionnaire (e-PRO) helps patients’ outcomes and support during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have had breast-conserving surgery followed by radiation
- You have at least grade 2 radiation-related breast fibrosis (severe scar tissue from radiation)
- Your breast radiation planning records are available
- Recent blood tests (within 15 days) are within limits for kidney, liver, and (if age 70+) muscle enzymes
- You can take pravastatin safely (no known allergy or related contraindications) and can give consent
- You are covered by the French Social Security system (and follow pregnancy/conscience rules if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses individual measures of how sensitive your body’s tissues are to radiation to guide after-surgery breast radiation treatment. It aims to keep treatment safe and effective while tailoring the plan to each person.
This trial tests a new way to deliver radiation therapy that adapts to each patient's body changes during treatment. It is for women who had breast cancer surgery and need radiation to the whole breast and nearby lymph nodes, and who have been identified as being at risk for breast fibrosis.
This trial studies a type of radiation made with proton beams given after mastectomy and implant reconstruction to lower breast cancer coming back. It’s for people who need additional (adjuvant) radiation and have not had prior radiation to the chest or breast.
This trial tests whether a spa therapy program can improve “fibrosis,” or stiffened/scarred tissue and related skin problems, after radiotherapy for breast cancer or upper head/neck cancers. It aims to see if treatment can improve quality of life for people who still have moderate-to-worse symptoms months after radiation.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
This study tests whether a common cholesterol-lowering drug (pravastatin, a type of statin) can reduce swallowing problems caused by past radiation for head and neck cancer. If you have had radiation at least 2 years ago and still have trouble swallowing, this trial may help find a new way to ease those symptoms.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.